(Q80348054)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508194%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

[Coenzyme Q10 in Parkinson's disease. Symptomatic or neuroprotective effects?] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508194%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

A Storch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508194%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508194%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508194%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508194%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508194%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

1378-1382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508194%20AND%20SRC:MED&resulttype=core&format=json

Superoxide activates mitochondrial uncoupling proteins

30 December 2019

cites work

1 reference

12 December 2020

Serum levels of coenzyme Q10 in patients with Parkinson's disease

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease

1 reference

12 December 2020

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

1 reference

12 December 2020

Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice

1 reference

12 December 2020

Effect of coenzyme Q10 on the mitochondrial function of skin fibroblasts from Parkinson patients

1 reference

12 December 2020

Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect

1 reference

12 December 2020

Parkinson's disease. Second of two parts

1 reference

12 December 2020

The essential functions of coenzyme Q.

1 reference

12 December 2020

Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects

1 reference

12 December 2020

Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease

1 reference

12 December 2020

Effect of coenzyme Q(10) and alpha-tocopherol content of mitochondria on the production of superoxide anion radicals

1 reference

12 December 2020

Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)

1 reference

12 December 2020

Therapeutic effects of coenzyme Q10 in neurodegenerative diseases

1 reference

12 December 2020

Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up

1 reference

12 December 2020

Serum levels of coenzyme Q10 in patients with Alzheimer's disease

1 reference

12 December 2020

Oxidative stress to dopaminergic neurons as models of Parkinson's disease

1 reference

12 December 2020

Coenzyme Q 10 improves lactic acidosis, strokelike episodes, and epilepsy in a patient with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes).

1 reference

12 December 2020

Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency

1 reference

12 December 2020

Biochemical, physiological and medical aspects of ubiquinone function

1 reference

12 December 2020

Coenzyme Q10: absorption, antioxidative properties, determinants, and plasma levels

1 reference

12 December 2020

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

12 December 2020

Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone

1 reference

12 December 2020

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

1 reference

12 December 2020

Mitochondrial dysfunction in neurodegenerative disorders

1 reference

12 December 2020

Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients

1 reference

12 December 2020

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

1 reference

12 December 2020

Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders

1 reference

12 December 2020

The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic

1 reference

12 December 2020

MPTP as a mitochondrial neurotoxic model of Parkinson's disease

1 reference

12 December 2020

Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue

1 reference

12 December 2020

Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease

1 reference

12 December 2020

Parkinson's disease. First of two parts

1 reference

12 December 2020

A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease

1 reference

12 December 2020

Serum levels of coenzyme Q10 in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Coenzyme Q is an obligatory cofactor for uncoupling protein function

1 reference

12 December 2020